TRABECTEDIN
| Brand name | YONDELIS |
|---|---|
| Active ingredient | TRABECTEDIN |
| Strength | 1MG/VIAL |
| Dosage form | POWDER |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | October 2015 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8895557*PED | July 2028 | — |
| 8895557 | January 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.